Skip to content
The GLP-1 Verdict
Menu
Ranked #207 · Grade C

Found review

An insurance-brokered GLP-1 marketplace whose $99/mo headline is the best of four different prices, unlocked only with both insurance and a 12-month prepay.

Visit Found Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $99/mo with insurance (12-mo prepaid), $169/mo cash-pay (12-mo prepaid), $199/mo with insurance monthly, $289/mo cash-pay monthly
Tirzepatide
From $99/mo with insurance (12-mo prepaid), $169/mo cash-pay (12-mo prepaid), $199/mo with insurance monthly, $289/mo cash-pay monthly
Coverage
Most states (exact exclusion list not published)
Brand-name
Yes

The scorecard

Found scored on our six published factors. See the methodology.

Real-world results68/100
Price honesty45/100
Prescriber access70/100
Formulary choice88/100
Cancellation fairness55/100
Member support65/100

What we like

  • Genuinely broad formulary: compounded semaglutide and tirzepatide, four brand GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound) and the oral pill Foundayo (orforglipron), plus non-GLP-1 options like Contrave and metformin
  • Real insurance brokering, not just a marketing claim — partners with Blue Cross, United Healthcare, Aetna, Cigna and Anthem, and most members reportedly pay under $30/visit
  • A new Medicare GLP-1 Bridge program gets eligible Part D members brand Wegovy, Zepbound or Foundayo for a flat $50/mo copay
  • Publishes molecule-specific outcome data with a methodology footnote (16% average loss on GLP-1 injections; 12.1% in 6 months on tirzepatide for treatment-naive members) rather than one generic number

The caveats

  • The advertised $99/mo is a floor that requires insurance approval AND a 12-month prepaid commitment — without both, the real price is $169–$289/mo, up to 2.9x the headline
  • Both molecules are priced as one undifferentiated "GLP-1 program" fee rather than a per-drug figure
  • Brand-name self-pay is materially more expensive: Ozempic and Mounjaro run roughly $1,100/mo, Wegovy and Zepbound from $650/mo+
  • The $50/mo Medicare copay is a named, time-limited bridge program (through December 2027), not a standing price
  • No specific list of excluded states is published, only a generic disclaimer that coverage varies by state
  • Compounded semaglutide and tirzepatide are not FDA-approved

The verdict

Best for: Insured patients willing to prepay a year up front, or Medicare Part D members eligible for the time-limited $50/mo brand-name bridge program. An insurance-brokered GLP-1 marketplace whose $99/mo headline is the best of four different prices, unlocked only with both insurance and a 12-month prepay.

Ranked #207 of 509 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. On the board it sits between Fierce Health, 68/100 above and System Labs at 65/100 below, with the Belle Health ruling the next one down.

Weighing it against something else? Every provider we would put in front of Found is ranked on price honesty, prescriber access and cancellation terms. We have also ruled on it directly: CoreAge Rx vs Found goes to CoreAge Rx, 94/100 to 65/100.

Visit Found

Compare with other providers

All 508 other providers we've reviewed, in our overall ranking order.

Every other program we track (502)

Pricing, states and verification reflect Found's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Found's site. Not medical advice; see our disclosure.

← Back to all rankings